Friday, April 23, 2021

NERv Technology Raises $3.32 Million as it Prepares to Bring Medical Sensor Tech to Market

NErv Technology team

NERv Technology, a Kitchener-Waterloo-based startup offering a sensory platform designed for the healthtech sector, has closed a $3.32 million CAD ($2.65 million USD) seed round of funding.

The seed round was led by returning investor SOSV, with participation from Graphene Ventures, OneValley, Northspring Capital Partners, Boutique Venture Partners, and Threshold Impact. A number of additional undisclosed strategic investors, angels, and physicians also invested in the round.

Wednesday, April 7, 2021

Finding new ways to manufacture red blood cells

Membio banner

Every year, more than 4.5 million people need blood transfusions in Canada and the United States. That amounts to about 36,000 RBC units per day for the US alone. Transfusions are needed for trauma response, surgery and cancer care. The medical system relies on a complex system of blood donations to meet that need. Without a sufficient, reliable supply of safe blood, the health-care system comes into jeopardy.

That’s where Shane Kilpatrick (MASc ’17, MBET ’18) and his company, Membio, is working to make a difference. The Canadian startup is developing technology to manufacture fully functioning red blood cells at an industrial scale.